These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9602658)

  • 1. Subpectoral implantation of a cardioverter defibrillator under local anaesthesia.
    Lipscomb KJ; Linker NJ; Fitzpatrick AP
    Heart; 1998 Mar; 79(3):253-5. PubMed ID: 9602658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantation of a unipolar cardioverter/defibrillator system under local anaesthesia.
    Stix G; Anvari A; Grabenwöger M; Merhaut C; Türel Z; Laufer G; Schmidinger H
    Eur Heart J; 1996 May; 17(5):764-8. PubMed ID: 8737108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and acceptability of implantation of internal cardioverter-defibrillators under local anesthetic and conscious sedation.
    Fox DJ; Davidson NC; Royle M; Bennett DH; Clarke B; Garratt CJ; Hall MC; Zaidi AM; Patterson K; Fitzpatrick AP
    Pacing Clin Electrophysiol; 2007 Aug; 30(8):992-7. PubMed ID: 17669082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local anaesthesia versus general anaesthesia for cardioverter-defibrillator implantation.
    Stix G; Anvari A; Podesser B; Pernerstorfer T; Mayer C; Laufer G; Schmidinger H
    Wien Klin Wochenschr; 1999 May; 111(10):406-9. PubMed ID: 10413834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conscious sedation during subcutaneous implantable cardioverter-defibrillator implantation using the intermuscular technique.
    Kaya E; Jánosi RA; Azizy O; Wakili R; Rassaf T
    J Interv Card Electrophysiol; 2019 Jan; 54(1):59-64. PubMed ID: 30218237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anesthesia care for subcutaneous implantable cardioverter/defibrillator placement: a single-center experience.
    Essandoh MK; Portillo JG; Weiss R; Otey AJ; Zuleta-Alarcon AN; Humeidan ML; Torres JL; Flores AS; Castellon-Larios K; Abdel-Rasoul M; Andritsos MJ; Perez WJ; Stein EJ; Turner KR; Dimitrova GT; Awad H; Bhandary SP; Tripathi RS; Joseph NC; Hummel JD; Augostini RS; Kalbfleisch SJ; Tyler JD; Houmsse M; Daoud EG
    J Clin Anesth; 2016 Jun; 31():53-9. PubMed ID: 27185678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of cardioverter-defibrillator implanted under conscious sedation in prepectoral subfascial position.
    Pacifico A; Wheelan KR; Nasir N; Wells PJ; Doyle TK; Johnson SA; Henry PD
    Circulation; 1997 Feb; 95(4):946-50. PubMed ID: 9054755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial experience with implantation of internal cardioverter/defibrillators under local anaesthesia by electrophysiologists.
    Schmitt C; Alt E; Plewan A; Schömig A
    Eur Heart J; 1996 Nov; 17(11):1710-6. PubMed ID: 8922920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of implantation of a cardioverter-defibrillator without general anesthesia in an electrophysiology laboratory.
    Tung RT; Bajaj AK
    Am J Cardiol; 1995 May; 75(14):908-12. PubMed ID: 7732999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can we implant cardioverter defibrillator under minimal sedation?
    Marquié C; Duchemin A; Klug D; Lamblin N; Mizon F; Cordova H; Boulo M; Lacroix D; Pol A; Kacet S
    Europace; 2007 Jul; 9(7):545-50. PubMed ID: 17483529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and safety of using local anaesthesia with conscious sedation during complex cardiac implantable electronic device procedures.
    Kaya E; Südkamp H; Lortz J; Rassaf T; Jánosi RA
    Sci Rep; 2018 May; 8(1):7103. PubMed ID: 29740019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled sedation with midazolam and analgesia with nalbuphine to alleviate pain in patients undergoing subcutaneous implantable cardioverter defibrillator implantation.
    Peyrol M; Barraud J; Cautela J; Maille B; Laine M; Bonello L; Thuny F; Paganelli F; Franceschi F; Koutbi L; Levy S
    J Interv Card Electrophysiol; 2017 Aug; 49(2):191-196. PubMed ID: 28536837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of defibrillation testing at the time of implantable cardioverter-defibrillator insertion.
    Hadid C; Atienza F; Strasberg B; Arenal Á; Codner P; González-Torrecilla E; Datino T; Percal T; Almendral J; Ortiz M; Martins R; Martinez-Alzamora N; Fernandez Aviles F
    Cardiol J; 2015; 22(3):253-9. PubMed ID: 25179316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioverter-defibrillator implantation and generator replacement in the octogenarian.
    Goonewardene M; Barra S; Heck P; Begley D; Fynn S; Virdee M; Grace A; Agarwal S
    Europace; 2015 Mar; 17(3):409-16. PubMed ID: 25341742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic prolonged QT interval and QT dispersion: the effects of propofol during implantation of cardioverter-defibrillator.
    Michaloudis D; Fraidakis O; Kanoupakis E; Flossos A; Manios E
    Eur J Anaesthesiol; 1999 Dec; 16(12):842-7. PubMed ID: 10747214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subpectoral cardioverter-defibrillator implantation using a lateral approach.
    Costeas XF; Strembelas PG; Markou DX; Stefanadis CI; Toutouzas PK
    J Interv Card Electrophysiol; 2000 Dec; 4(4):611-9. PubMed ID: 11141208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.